| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | -55.2% |
| Cost of Revenue | $17.3M | +15.7% |
| Gross Profit | -$15.8M | -36.3% |
| R&D Expense | $3.3M | -50.0% |
| SG&A Expense | $14.7M | +20.2% |
| Operating Income | -$59.2M | -12.3% |
| Income Tax | $0 | +100.0% |
| Net Income | -$57.5M | -13.0% |
| EPS (Basic) | -$0.02 | +0.0% |
| EPS (Diluted) | -$0.02 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $15.9M | +0.0% |
| Accounts Receivable | $41K | -55.4% |
| Inventory | $18.8M | -22.3% |
| Current Assets | $48.9M | +3.9% |
| Total Assets | $69.3M | -4.8% |
| Current Liabilities | $11.6M | -6.8% |
| Total Liabilities | $15.2M | -22.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.2M | -22.9% |
| Capital Expenditures | $178K | -85.7% |
| Investing Cash Flow | $14.9M | +33.6% |
| Financing Cash Flow | $55.6M | +283.2% |
| Free Cash Flow | -$47.4M | -19.5% |
| $54.0M |
| +1.7% |